Ledger.Open graph →
SEC Form D · filed November 7, 2018

Wize Pharma, Inc

Offering
$4.5M
Sold
$4.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
HOD HASHARON, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Yossi Keret · Hod Hasharon, L3DirectorJoseph Zarzewsky · Hod Hasharon, L3DirectorNoam Danenberg · Hod Hasharon, L3ExecMichael Belkin · Hod Hasharon, L3DirectorRon Mayron · Hod Hasharon, L3DirectorFranck Amouyal · Hod Hasharon, L3DirectorOr Eisenberg · Hod Hasharon, L3ExecJoseph Zarzewsky · Hod Hasharon, L3DirectorNoam Danenberg · Hod Hasharon, L3ExecMichael Belkin · Hod Hasharon, L3DirectorRon Mayron · Hod Hasharon, L3DirectorFranck Amouyal · Hod Hasharon, L3DirectorYossi Keret · Hod Hasharon, L3DirectorOr Eisenberg · Hod Hasharon, L3Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗